Aging
Featured Topics
Lead story
Other featured articles
-
Pilot Funding Available for Researchers of Alzheimer’s, Aging
Pilot funding amounts range from $25,000 to up to $45,000. An informational session on the application process will be held over zoom on Thursday, December 9, 2021, at 10:00 a.m. pacific.
Posted in -
Applying for the 2022-2023 Roybal Center for Behavioral Interventions in Aging Pilot Projects
The Roybal Center for Behavioral Interventions in Aging seeks proposals for pilot projects that involve randomized controlled trials (RCTs).
-
The Costs of Developing Treatments for Alzheimer’s Disease: A Retrospective Exploration
With the exception of the recent accelerated approval of aducanumab, in over 26 years of research and development (R&D) investment in Alzheimer’s disease (AD), only five novel drugs—all for symptomatic treatment only—have reached FDA approval. Here, we estimate the costs of AD drug development during this period in the private sector.
Posted in -
NAM Expert Briefing on Behavioral and Social Science Research Questions Raised By the Use of Biomarkers for Alzheimer’s Disease Diagnostics
On June 28 and 29, 2021, the National Academies of Sciences, Engineering, and Medicine convened an expert meeting that addressed behavioral and social science research questions raised by the use of biomarkers and other measures for pre-clinical AD/ADRD diagnosis
About this section
People are living longer, which brings obvious benefits as well as considerable challenges — from Alzheimer’s and other age-related diseases to increased injuries, disabilities and poverty risks. Policymakers around the world rely on Schaeffer Center research and modeling tools for finding ways to help keep people as healthy as possible throughout their lives.
Our Experts On Aging
Our Work In Aging
-
NAS Report Outlines Priorities for the Next Ten Years of Alzheimer’s Research
Julie Zissimopoulos participated on the committee tasked with developing the research agenda.
-
Advancing the Economics of Palliative Care: The Value to Individuals and Families, Organizations, and Society
A palliative care research agenda can help lay the foundation for building a strong evidence base to guide public policies meant to advance affordable, equitable, high-quality, patient-centered care.
Categorized in -
Leveraging Behavioral Sciences for Dementia Care
Insights from the behavioral sciences may help doctors detect dementia earlier and develop more insightful care plans.
-
Disparate Aging: The Role of Education and Socioeconomic Gradients in Future Health and Disability in an International Context
If on one side ageing is driven by biological changes, on the other side the ageing itself reflects the accumulated effects of one’s exposure to a history of external risks, and can further be influenced by social changes, such as isolation and loss of loved ones.
Categorized in -
FDA’s Approval of Aducanumab Paves the Way for ‘More Momentous’ Alzheimer’s Breakthroughs
The FDA’s recent approval of the first disease-modifying therapy for Alzheimer’s will fuel the chances of even more breakthroughs.
-
Examining Primary Care Physician Rationale for not Following Geriatric Choosing Wisely Recommendations
Why do physicians order tests or treatments in older adults contrary to published recommendations?
Categorized in